JP Morgan Chase’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,257
| Closed | -$622K | – | 6857 |
|
|
2021
Q1 | $622K | Sell |
5,257
-30
| -0.6% | -$3.55K | ﹤0.01% | 4543 |
|
|
2020
Q4 | $624K | Buy |
5,287
+7
| +0.1% | +$813 | ﹤0.01% | 4252 |
|
|
2020
Q3 | $587K | Sell |
5,280
-57,103
| -92% | -$6.13M | ﹤0.01% | 3909 |
|
|
2020
Q2 | $6.37M | Buy |
62,383
+44,336
| +246% | +$4.74M | ﹤0.01% | 2268 |
|
|
2020
Q1 | $1.95M | Buy |
18,047
+8,154
| +82% | +$937K | ﹤0.01% | 2986 |
|
|
2019
Q4 | $1.15M | Buy |
9,893
+2,779
| +39% | +$322K | ﹤0.01% | 3751 |
|
|
2019
Q3 | $814K | Sell |
7,114
-2,500
| -26% | -$249K | ﹤0.01% | 3946 |
|
|
2019
Q2 | $917K | Hold |
9,614
| – | – | ﹤0.01% | 3920 |
|
|
2019
Q1 | $877K | Sell |
9,614
-2
| -0% | -$164 | ﹤0.01% | 3891 |
|
|
2018
Q4 | $730K | Buy |
9,616
+2
| +0% | +$147 | ﹤0.01% | 3924 |
|
|
2018
Q3 | $769K | Sell |
9,614
-4,400
| -31% | -$410K | ﹤0.01% | 4056 |
|
|
2018
Q2 | $1.39M | Buy |
14,014
+8,800
| +169% | +$760K | ﹤0.01% | 3648 |
|
|
2018
Q1 | $422K | Sell |
5,214
-2,113
| -29% | -$171K | ﹤0.01% | 4079 |
|
|
2017
Q4 | $577K | Sell |
7,327
-1,373
| -16% | -$114K | ﹤0.01% | 4008 |
|
|
2017
Q3 | $795K | Buy |
+8,700
| New | +$836K | ﹤0.01% | 3627 |
|
|
2016
Q4 | – | Sell |
-37,208
| Closed | -$4.63M | – | 5272 |
|
|
2016
Q3 | $4.63M | Buy |
+37,208
| New | +$4.39M | ﹤0.01% | 2305 |
|
|
2016
Q2 | – | Sell |
-20,644
| Closed | -$2.36M | – | 5135 |
|
|
2016
Q1 | $2.36M | Buy |
+20,644
| New | +$2.42M | ﹤0.01% | 2614 |
|
|
2015
Q3 | – | Sell |
-30,844
| Closed | -$3.55M | – | 4222 |
|
|
2015
Q2 | $3.55M | Sell |
30,844
-34,212
| -53% | -$3.59M | ﹤0.01% | 2593 |
|
|
2015
Q1 | $6.21M | Buy |
+65,056
| New | +$4.87M | ﹤0.01% | 2200 |
|
|
2014
Q4 | – | Sell |
-5,234
| Closed | -$283K | – | 4468 |
|
|
2014
Q3 | $283K | Buy |
+5,234
| New | +$258K | ﹤0.01% | 3881 |
|
JP Morgan Chase's CBPO Position: Q2 2021 in Review
JP Morgan Chase sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 5,257 shares — an estimated $622K sold.
JP Morgan Chase first reported a position in CBPO in Q3 2014 and held it in 20 quarters. The position peaked at $6.37M in Q2 2020. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- JP Morgan Chase reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- JP Morgan Chase sold 5,257 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $622K.
- JP Morgan Chase first reported a position in China Biologic Products Holdings, Inc. in Q3 2014 and held it in 20 quarters.
- JP Morgan Chase's China Biologic Products Holdings, Inc. position peaked at $6.37M in Q2 2020.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.